These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 19059057)

  • 1. Fundamentals of pharmacology and applications in pharmacogenetics.
    Al-Ghoul M; Valdes R
    Clin Lab Med; 2008 Dec; 28(4):485-97. PubMed ID: 19059057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics in Europe: barriers and opportunities.
    Gurwitz D; Zika E; Hopkins MM; Gaisser S; Ibarreta D
    Public Health Genomics; 2009; 12(3):134-41. PubMed ID: 19204415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic factors in drug metabolism.
    Belle DJ; Singh H
    Am Fam Physician; 2008 Jun; 77(11):1553-60. PubMed ID: 18581835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fundamentals of Pharmacogenetics in Personalized, Precision Medicine.
    Valdes R; Yin DT
    Clin Lab Med; 2016 Sep; 36(3):447-59. PubMed ID: 27514461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fundamentals and applications of pharmacogenetics for the clinical laboratory.
    Linder MW; Valdes R
    Ann Clin Lab Sci; 1999; 29(2):140-9. PubMed ID: 10219702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics in drug development.
    McCarthy AD; Kennedy JL; Middleton LT
    Philos Trans R Soc Lond B Biol Sci; 2005 Aug; 360(1460):1579-88. PubMed ID: 16096107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacogenetics: towards personalized medicine].
    Gurwitz D; Rehavi M
    Harefuah; 2005 Oct; 144(10):711-6, 750. PubMed ID: 16281764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consumers' views of pharmacogenetics--A qualitative study.
    Haddy CA; Ward HM; Angley MT; McKinnon RA
    Res Social Adm Pharm; 2010 Sep; 6(3):221-31. PubMed ID: 20813335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics: the Dx perspective.
    Cartwright CP
    Expert Rev Mol Diagn; 2001 Nov; 1(4):371-6. PubMed ID: 11901851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualized drug and dose: the clinical pharmacologist's calling or curse?
    Begg EJ
    Clin Exp Pharmacol Physiol; 2005 Nov; 32(11):975-8. PubMed ID: 16405455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacoepigenetics: its role in interindividual differences in drug response.
    Gomez A; Ingelman-Sundberg M
    Clin Pharmacol Ther; 2009 Apr; 85(4):426-30. PubMed ID: 19242404
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacogenetics in the clinical analysis laboratory: clinical practice, research, and drug development pipeline.
    Miscio G; Paroni G; Bisceglia P; Gravina C; Urbano M; Lozupone M; Piccininni C; Prisciandaro M; Ciavarella G; Daniele A; Bellomo A; Panza F; Di Mauro L; Greco A; Seripa D
    Expert Opin Drug Metab Toxicol; 2019 Sep; 15(9):751-765. PubMed ID: 31512953
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-metabolizing enzymes: evidence for clinical utility of pharmacogenomic tests.
    Andersson T; Flockhart DA; Goldstein DB; Huang SM; Kroetz DL; Milos PM; Ratain MJ; Thummel K
    Clin Pharmacol Ther; 2005 Dec; 78(6):559-81. PubMed ID: 16338273
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacogenomics and gene expression analysis. Functional genome research for individual application to patients].
    Kassack MU
    Med Monatsschr Pharm; 2003 May; 26(5):165-6. PubMed ID: 12784508
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacogenetic biomarkers for predicting drug response.
    Bank PC; Swen JJ; Guchelaar HJ
    Expert Rev Mol Diagn; 2014 Jul; 14(6):723-35. PubMed ID: 24857685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BeadArray-based solutions for enabling the promise of pharmacogenomics.
    Fan JB; Hu S; Craumer W; Barker D
    Biotechniques; 2005 Oct; 39(10 Suppl):S583-8. PubMed ID: 18957041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PhRMA white paper on ADME pharmacogenomics.
    Williams JA; Andersson T; Andersson TB; Blanchard R; Behm MO; Cohen N; Edeki T; Franc M; Hillgren KM; Johnson KJ; Katz DA; Milton MN; Murray BP; Polli JW; Ricci D; Shipley LA; Vangala S; Wrighton SA
    J Clin Pharmacol; 2008 Jul; 48(7):849-89. PubMed ID: 18524998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic advantage of pharmacogenomics - clinical trials with genetic information.
    Ohashi W; Mizushima H; Tanaka H
    Stud Health Technol Inform; 2008; 136():585-90. PubMed ID: 18487794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ethnic background related pharmacological differences].
    Reinbold H
    MMW Fortschr Med; 2007 Oct; 149(42):34, 36. PubMed ID: 17987717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collaborative Counseling Considerations for Pharmacogenomic Tests.
    Zierhut HA; Campbell CA; Mitchell AG; Lemke AA; Mills R; Bishop JR
    Pharmacotherapy; 2017 Sep; 37(9):990-999. PubMed ID: 28672074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.